Caffeine,
decoded.

A 250 mg dose produced a larger acute BP rise in men with hypertension. Long-term effects are likely small for most habitual users because tolerance develops, but high intake, severe hypertension, energy drinks, and heightened sensitivity merit caution. Energy drinks raise both systolic and diastolic BP and may elevate exercise BP.

Across 28 prospective cohorts, risk was about 20% lower at 3.5 cups/day and 30% lower at 5 cups/day. Similar associations for decaf suggest chlorogenic acids, magnesium, chromium, and other coffee constituents matter. Small and mostly acute clinical trials remain inconsistent.

French press, Greek/Turkish, and Scandinavian boiled coffee contain the most cafestol; espresso and Moka contain less. Paper-filtered and instant coffee contain little. Randomized trials show cafestol capsules raise LDL, whereas caffeine capsules do not.

After cardioversion, randomization to at least 1 cup/day reduced recurrent AF by 39% versus caffeine avoidance. Guidelines advise clinicians not to routinely recommend caffeine avoidance solely to prevent AF. Energy-drink case reports in young, otherwise low-risk people remain a distinct concern.

Premature atrial contractions show no clear relationship. Premature ventricular contractions increased in randomized studies. Ventricular tachycardia was less common in one large cohort, but powder or capsule doses greater than 10 times a typical cup have caused ventricular fibrillation and sudden death in case reports.

Light (median 1.5 cups/day) and moderate (median 3.5) intake correlated with about 10% lower risk. UK Biobank data placed the lowest risk near 2-3 cups/day. Decaf associations and neutral genetic analyses again point toward noncaffeine coffee components.

No randomized HF outcome trials exist. Early-to-midlife low/moderate coffee consumption correlated with better LV systolic and diastolic function, while more than 4 cups/day correlated with worse LV function. Administrative outcome coding and limited HF phenotype detail constrain inference.

Coffee and tea cohorts generally favor moderate intake for total and ischemic stroke. Mendelian randomization found no causal link. Findings for caffeinated versus decaffeinated coffee differ across analyses, emphasizing residual confounding and beverage-component uncertainty.

Associations persist across diverse populations and after adjustment for smoking and lifestyle, and appear with both caffeinated and decaf coffee. Nevertheless, healthy-user bias, reverse causation, and residual confounding cannot be fully excluded.

Energy drinks raise resting and exercise BP and have preceded acute AF in case reports. Extremely high powder/capsule doses have caused VF and sudden death. Available energy-drink data are limited, but the overall signal favors cardiovascular harm rather than benefit.